Your Location：
Home >
Browse articles >
Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics
Updated：2026-07-16
Previous|Next

    • Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics

      Enhanced Publication
    • “Huoxin Pill may enhance the stability of vulnerable atherosclerotic plaques by regulating the PPAR γ/LXR α/ABCA1/ABCG1 signaling pathway and inhibiting inflammation, reducing lipid deposition and macrophage infiltration within plaques, thereby providing a new approach for the treatment of cardiovascular diseases.”
    • XIANG Jiao , LUO Jieying , LIAO Daiyuan , LI Fulai , YI Rui , LIANG Yong , MO Zunhui , LIU Dongyan , WANG Jiansong , WANG Lingli
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 16, Pages: 117-129(2026)

    • DOI： 10.13422/j.cnki.syfjx.20260568     

      CLC：

    • Revised：2026-05-13 ，

      Accepted：28 May 2026 ，

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 7 ) Tabs( 11 )

  • References

  • Publication Info

  • Metrics

227

Views

107

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Effect Difference and Mechanisms of Zishenwan Against Chronic Prostatitis Before and After Salt-processing of Anemarrhenae Rhizoma and Phellodendri Chinensis Cortex by Integrating Network Pharmacology and Metabolomics
Xuefu Zhuyutang Ameliorates Metabolic-associated Fatty Liver Disease via AMPK Signaling Pathway
Bioinformatics Reveals Mechanism of Zuoguiwan in Treating Polycystic Ovary Syndrome
Effect of Scutellariae Radix-Coptidis Rhizoma on Stabilization of Atherosclerotic Vulnerable Plaques via Inhibition of TLR4/MyD88/NF-κB Signaling Pathway
Pinelliae Rhizoma and Its Prescription Compatibility for Depression Treatment： A Review

Related Author

ZHAO Shangling
MENG Xiao
LI Sirui
TAN Rui
HU Changjiang
YU Lingying
CHEN Zhimin
HAN Ming

Related Institution

Key Laboratory of Chinese Medicine Germplasm Resources Innovation and Effective Uses in Sichuan Province，School of Pharmacy，School of Modern Chinese Medicine Industry， Chengdu University of Traditional Chinese Medicine
School of Life Science and Engineering，Southwest Jiaotong University
School of Integrated Chinese and Western Medicine， Hebei University of Chinese Medicine
The Third Hospital of Hebei Medical University
Hebei International Cooperation Center for Ion Channel Function and Innovative Traditional Chinese Medicine